Skip to main content
Premium Trial:

Request an Annual Quote

Definiens, MolecularMD Partner to Provide Quantitative Tissue Assays for Oncology

NEW YORK (GenomeWeb) –Definiens and MolecularMD said today that they will partner to provide customized diagnostic solutions in oncology.

Definiens specializes in what it calls "tissue phenomics" for biomarker and companion diagnostics development and commercialization. MolecularMD develops custom molecular diagnostic products and supports clinical trial services for targeted cancer therapies.

Under the partnership, the companies plan to combine MolecularMD's expertise in specialty diagnostic assays with Definiens' quantitative tissue read-outs in order to provide custom solutions that meet data and regulatory requirements for both biopharmaceutical clients and academic medical center oncology programs.

"This agreement brings together MolecularMD's proven track record in clinical assay development and companion diagnostics with Definiens' unparalleled image analysis platform to provide the confidence of an integrated solution in stratifying patients," Definiens chief commercial officer Merrilyn Datta said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.